(Q39663357)

13 September 2017

title

Pharicin B stabilizes retinoic acid receptor-α and presents synergistic differentiation induction with ATRA in myeloid leukemic cells (English)

1 reference

13 September 2017

1 reference

1 reference

9

Han-Dong Sun

1 reference

13 September 2017

Zhi-Min Gu

1

1 reference

13 September 2017

Ying-Li Wu

2

1 reference

13 September 2017

Mei-Yi Zhou

3

1 reference

13 September 2017

Chuan-Xu Liu

4

1 reference

13 September 2017

Han-Zhang Xu

5

1 reference

13 September 2017

Hua Yan

6

1 reference

13 September 2017

Yong Zhao

7

1 reference

13 September 2017

Ying Huang

8

1 reference

13 September 2017

Guo-Qiang Chen

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

25 August 2010

1 reference

full work available at URL

13 September 2017

http://www.bloodjournal.org/content/bloodjournal/116/24/5289.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739655

http://www.bloodjournal.org/cgi/content/abstract/116/24/5289

23 June 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739655

http://ashpublications.org/blood/article-pdf/116/24/5289/1462094/zh805010005289.pdf

23 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

23 June 2024

1 reference

13 September 2017

volume

116

1 reference

13 September 2017

issue

24

1 reference

13 September 2017

page(s)

5289-5297

1 reference

Guiding ligands to nuclear receptors

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Retinoic acid receptors, hematopoiesis and leukemogenesis

23 June 2024

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Reconstructing a disease: What essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia?

23 June 2024

3

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.

23 June 2024

4

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice

23 June 2024

5

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.

23 June 2024

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation

23 June 2024

7

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Curing APL: differentiation or destruction?

23 June 2024

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Retinoic acid resistance in acute promyelocytic leukemia

23 June 2024

9

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

23 June 2024

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Nuclear proteins: promising targets for cancer drugs

23 June 2024

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

RAR and RXR modulation in cancer and metabolic disease

23 June 2024

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells

23 June 2024

14

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent

23 June 2024

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Antileukemic roles of human phospholipid scramblase 1 gene, evidence from inducible PLSCR1-expressing leukemic cells

23 June 2024

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

E3 ligase FLRF (Rnf41) regulates differentiation of hematopoietic progenitors by governing steady-state levels of cytokine and retinoic acid receptors

23 June 2024

17

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins

23 June 2024

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Multiplicity generates diversity in the retinoic acid signalling pathways

23 June 2024

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene

23 June 2024

21

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Coactivator and corepressor complexes in nuclear receptor function

23 June 2024

22

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes

23 June 2024

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia

23 June 2024

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

CD14: cell surface receptor and differentiation marker

23 June 2024

28

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

RARalpha antagonist Ro 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines

23 June 2024

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes

23 June 2024

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones

23 June 2024

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line

23 June 2024

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities.

23 June 2024

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

23 June 2024

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner.

23 June 2024

38

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.

23 June 2024

41

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Acute promyelocytic leukemia--weapons of mass differentiation.

23 June 2024

43

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.

23 June 2024

44

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha

23 June 2024

45

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR alpha and calcium-dependent signaling

23 June 2024

47

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells

23 June 2024

48

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia

23 June 2024

49

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Hydroxyurea indices precommitment during retinoic induced HL-60 terminal myeloid differentiation: possible involvement of gene amplification.

23 June 2024

50

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells

23 June 2024

51

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors

23 June 2024

52

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-02-267963

23 June 2024

Identifiers

1 reference

13 September 2017

1 reference